BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 2427817)

  • 1. The electrophysiological effects of dicentrine on the conduction system of rabbit heart.
    Young ML; Su MJ; Wu MH; Chen CC
    Br J Pharmacol; 1994 Sep; 113(1):69-76. PubMed ID: 7812635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding the pharmacology of amiodarone.
    Nattel S; Talajic M
    Drugs; 1988 Aug; 36(2):121-31. PubMed ID: 2460307
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
    Gill J; Heel RC; Fitton A
    Drugs; 1992 Jan; 43(1):69-110. PubMed ID: 1372862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    Kannan R; Miller S; Singh BN
    Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.
    Kodama I; Kamiya K; Toyama J
    Am J Cardiol; 1999 Nov; 84(9A):20R-28R. PubMed ID: 10568656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and critical comparison of internal standards for the routine liquid chromatographic assay of amiodarone and desethylamiodarone.
    Pollak PT
    Ther Drug Monit; 1996 Apr; 18(2):168-78. PubMed ID: 8721281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
    Nattel S
    J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.